The NORAD Lncrna Assembles a Topoisomerase Complex Critical for Genome Stability Mathias Munschauer1*, Celina T

Total Page:16

File Type:pdf, Size:1020Kb

The NORAD Lncrna Assembles a Topoisomerase Complex Critical for Genome Stability Mathias Munschauer1*, Celina T Corrected: Publisher Correction LETTER https://doi.org/10.1038/s41586-018-0453-z The NORAD lncRNA assembles a topoisomerase complex critical for genome stability Mathias Munschauer1*, Celina T. Nguyen1, Klara Sirokman1, Christina R. Hartigan1, Larson Hogstrom1, Jesse M. Engreitz1, Jacob C. Ulirsch1,2,3, Charles P. Fulco1, Vidya Subramanian1, Jenny Chen1,4, Monica Schenone1, Mitchell Guttman5, Steven A. Carr1 & Eric S. Lander1,6,7* The human genome contains thousands of long non-coding RNAs1, cytoplasmic extracts, which may not accurately represent the protein but specific biological functions and biochemical mechanisms contacts of NORAD in living cells (Supplementary Note 1). have been discovered for only about a dozen2–7. A specific long To reveal the direct interactions of NORAD with proteins in live non-coding RNA—non-coding RNA activated by DNA damage cells, we captured and identified NORAD-interacting proteins by (NORAD)—has recently been shown to be required for maintaining combining RNA antisense purification (RAP) with quantitative liquid genomic stability8, but its molecular mechanism is unknown. Here chromatography–mass spectrometry using isobaric mass tag quantifi- we combine RNA antisense purification and quantitative mass cation (RAP MS) (Fig. 1a). HCT116 colon carcinoma cells were treated spectrometry to identify proteins that directly interact with NORAD with 365-nm light after 4-thiouridine labelling10, which covalently in living cells. We show that NORAD interacts with proteins involved crosslinks proteins to RNA but not to other proteins. lncRNA– in DNA replication and repair in steady-state cells and localizes protein complexes were purified by RNA hybrid selection with to the nucleus upon stimulation with replication stress or DNA antisense oligonucleotides that target NORAD, under denaturing damage. In particular, NORAD interacts with RBMX, a component and reducing conditions at high temperature to minimize the co- of the DNA-damage response, and contains the strongest RBMX- purification of indirectly bound proteins2 (Fig. 1a). To identify specific binding site in the transcriptome. We demonstrate that NORAD interactors with NORAD, we quantitatively compared the resulting pro- controls the ability of RBMX to assemble a ribonucleoprotein teins to those captured in purifications with antisense oligonucleotides complex—which we term NORAD-activated ribonucleoprotein that target the well-characterized ‘RNA component of mitochondrial complex 1 (NARC1)—that contains the known suppressors of RNA processing endoribonuclease’ (RMRP), which is not expected to genomic instability topoisomerase I (TOP1), ALYREF and the interact with the same proteins as NORAD 11. We analysed biological PRPF19–CDC5L complex. Cells depleted for NORAD or RBMX replicate purifications in a single 4-plex iTRAQ cassette, quantifying display an increased frequency of chromosome segregation 1,361 proteins that each had more than two unique peptides (Fig. 1b). defects, reduced replication-fork velocity and altered cell-cycle The control purification captured about 85% of RMRP transcripts progression—which represent phenotypes that are mechanistically (Extended Data Fig. 1) and enriched the target RNA approximately linked to TOP1 and PRPF19–CDC5L function. Expression of 550-fold versus input RNA. We found 12 strongly enriched proteins NORAD in trans can rescue defects caused by NORAD depletion, (mean log2(iTRAQ ratio (NORAD/RMRP)) < −1.6, P < 0.05, moder- but rescue is significantly impaired when the RBMX-binding site ated t-test) (Fig. 1c), including 8 of the 10 known core components of in NORAD is deleted. Our results demonstrate that the interaction the RMRP complex11 and one previously identified candidate rRNA- between NORAD and RBMX is important for NORAD function, and and/or tRNA-processing factor12. that NORAD is required for the assembly of the previously unknown We then analysed NORAD antisense purifications. Experiments topoisomerase complex NARC1, which contributes to maintaining captured 82% of endogenous NORAD (Extended Data Fig. 1) (about genomic stability. In addition, we uncover a previously unknown 80-fold enrichment versus input RNA). We reproducibly identified function for long non-coding RNAs in modulating the ability of an 45 proteins that met our enrichment criteria (mean log2(iTRAQ ratio RNA-binding protein to assemble a higher-order ribonucleoprotein (NORAD/RMRP)) > 1.6, P < 0.05, moderated t-test) (Fig. 1b). This set complex. of proteins is highly specific to NORAD, in that 41 out of the 45 proteins NORAD stands out among long non-coding RNAs (lncRNAs) (Fig. 1c) were not among 219 promiscuous binders (Supplementary because it (1) is highly conserved relative to other lncRNAs, (2) is Note 3). The RNA-binding protein PUMILIO2 (PUM2) was indeed abundantly expressed in many cell types, (3) is upregulated upon DNA present in our NORAD interactome, but it ranked 185th out of damage and (4) induces chromosomal instability and aneuploidy when the 265 proteins we detected (mean log2(iTRAQ ratio (NORAD/ deleted. This phenotype is intriguing as little is known about the roles RMRP)) > 0.5) and did not meet our cut-off for strongly enriched of lncRNAs in maintaining a stable genome. A model for lncRNA proteins. function suggests that lncRNAs can serve as assembly scaffolds for Notably, many of the 41 NORAD-interacting proteins have key roles ribonucleoprotein complexes6,7, yet this model has been explored in in nuclear processes such as DNA unwinding, replication and repair only a few cases. The mechanism that connects the NORAD lncRNA (including PURA, PURB, TAF15, ALYREF, SFPQ, SRSF1, RBM14, to chromosomal instability remains unknown. DDX17, RBMX and its retrogene RBMXL1). Twenty-nine (71%) of Two recent studies have reported PUMILIO, a highly abundant cyto- the forty-one proteins localize to the nucleus, nucleoplasm or chro- plasmic RNA-binding protein with no known role in genomic stability, matin, whereas only two (5%) localize exclusively to the cytoplasm as the sole NORAD-interacting protein8,9. However, these results were (Fig. 1d). The interactome thus points towards an important nuclear obtained from in vitro mixing of exogenous NORAD fragments with function of NORAD. 1Broad Institute of MIT and Harvard, Cambridge, MA, USA. 2Division of Hematology/Oncology, Boston Children’s Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. 3Program in Biological and Biomedical Sciences, Harvard University, Cambridge, MA, USA. 4Division of Health Sciences and Technology, MIT, Cambridge, MA, USA. 5Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. 6Department of Biology, MIT, Cambridge, MA, USA. 7Department of Systems Biology, Harvard Medical School, Boston, MA, USA. *e-mail: [email protected]; [email protected] 132 | NATURE | VOL 561 | 6 SEPTEMBER 2018 © 2018 Springer Nature Limited. All rights reserved. LETTER RESEARCH 4 a Human 365 nm LC–MS/MS b RBMXL1 cell CSTF2 Ultraviolet crosslink TAF15 HNRNPR 4-thiouridine 2 RBMX PURA eplicate 2) KHDRBS3 ) r Identication Cell lysis, Quantication Biotin y antisense- RMRP / capture –4 –2 24 Intensit POP1 Denaturing RPP40 NORAD RPP25L m/z ( purication C18ORF21 –2 RPP14 POP4 POP5 Protein elution Trypsin NORAD RMRP NORAD RMRP –4 by benzonase digest rep 1 rep 1 rep 2 rep 2 (iTRAQ ratio RMRP mean log2 ratio < –1.6, P < 0.05 2 NORAD mean log2 ratio > 1.6, P < 0.05 Isobaric mass tag labelling log log2(iTRAQ ratio (NORAD/RMRP) replicate 1) c 10 RMRP enriched proteins NORAD enriched proteins NORAD interactome iTRAQ (RMRP/NORAD) 10 iTRAQ (NORAD/RMRP) d 100% Cytoplasm Nucleus & 5 80% 5 cytoplasm Chromatin iTRAQ ratio 60% Nucleoplasm 0 0 1 1 9 3 3 L 2 3 7 2 5 0 8 4 0 A R 40% LY A0 AB F15 TR3 FUS RA YREF DDX5 POP4 POP5 POP1 SFPQ PURA PURB RBM3 TA RBMX SF3A CIRBP Nucleus U2AF2 CSTF2 ALPK1 RPP2 RPP4 RPP3 RPP1 RPP3 SRSF SRSF SRSF DDX17 DDX3X PTPR PSPC MA 20% SUGP RBM47 RBM45 RBM14 KHSRP CHERP AL RPP25L SRSF10 AKAP8 DAZAP1 PPHLN1 LSM14B RBMXL1 IGF2BP IGF2BP HNRNP C3ORF17 HNRNP KHDRBS HNRNP C18ORF21 APOBEC3F 0% Fig. 1 | NORAD directly binds many nuclear proteins in living cells. of RMRP- (blue) and NORAD- (red) enriched proteins. Columns represent a, Schematic overview of RAP MS. b, Quantification of NORAD- and the mean of two biological replicate experiments, individual data points RMRP-interacting proteins. Scatter plot of log2-transformed iTRAQ ratios are shown (Supplementary Tables 1, 2). d, Subcellular localization of from two biological replicates is shown. Adjusted P value, two-tailed NORAD-interacting proteins. moderated t-test (Supplementary Note 2). Rep, replicate. c, iTRAQ ratios Given the overrepresentation of nuclear proteins, we used single- sequenced RNA crosslinked to RBMX. RBMX displays unusually molecule RNA fluorescent in situ hybridization (smRNA FISH) to strong and specific binding to the 5′ end of NORAD (Fig. 2e). The assess the subcellular localization of NORAD in intact cells. In contrast RBMX-binding site in NORAD extends over more than 800 nucleotides to previous reports that characterized NORAD as being located exclu- and covers about 15% of NORAD—making it eight times larger than sively in the cytoplasm8, we found that on average 40–50% of NORAD the majority of RBMX-binding sites (Extended Data Fig. 3d) and the transcripts in HCT116 cells reside in the nucleus (Fig. 2a and Extended strongest RBMX-binding region in the transcriptome (Fig. 2f). This Data
Recommended publications
  • Astrin-SKAP Complex Reconstitution Reveals Its Kinetochore
    RESEARCH ARTICLE Astrin-SKAP complex reconstitution reveals its kinetochore interaction with microtubule-bound Ndc80 David M Kern1,2, Julie K Monda1,2†, Kuan-Chung Su1†, Elizabeth M Wilson-Kubalek3, Iain M Cheeseman1,2* 1Whitehead Institute for Biomedical Research, Cambridge, United States; 2Department of Biology, Massachusetts Institute of Technology, Cambridge, United States; 3Department of Cell Biology, The Scripps Research Institute, La Jolla, United States Abstract Chromosome segregation requires robust interactions between the macromolecular kinetochore structure and dynamic microtubule polymers. A key outstanding question is how kinetochore-microtubule attachments are modulated to ensure that bi-oriented attachments are selectively stabilized and maintained. The Astrin-SKAP complex localizes preferentially to properly bi-oriented sister kinetochores, representing the final outer kinetochore component recruited prior to anaphase onset. Here, we reconstitute the 4-subunit Astrin-SKAP complex, including a novel MYCBP subunit. Our work demonstrates that the Astrin-SKAP complex contains separable kinetochore localization and microtubule binding domains. In addition, through cross-linking analysis in human cells and biochemical reconstitution, we show that the Astrin-SKAP complex binds synergistically to microtubules with the Ndc80 complex to form an integrated interface. We propose a model in which the Astrin-SKAP complex acts together with the Ndc80 complex to stabilize correctly formed kinetochore-microtubule interactions. *For correspondence: DOI: https://doi.org/10.7554/eLife.26866.001 [email protected] †These authors contributed equally to this work Introduction Competing interests: The The macromolecular kinetochore complex links chromosomes to dynamic microtubule polymers and authors declare that no harnesses the forces generated by microtubule growth and depolymerization to facilitate accurate competing interests exist.
    [Show full text]
  • Supplemental Material Table of Contents
    Supplemental material Table of Contents Detailed Materials and Methods ......................................................................................................... 2 Perioperative period ........................................................................................................................... 2 Ethical aspects ................................................................................................................................... 4 Evaluation of heart failure ................................................................................................................. 4 Sample preparation for ANP mRNA expression .................................................................................. 5 Sample preparation for validative qRT-PCR (Postn, Myh7, Gpx3, Tgm2) ............................................ 6 Tissue fibrosis .................................................................................................................................... 7 Ventricular remodeling and histological tissue preservation ................................................................ 8 Evaluation of the histological preservation of cardiac tissue ................................................................ 9 Sample preparation and quantitative label-free proteomics analyses .................................................. 10 Statistical methods ........................................................................................................................... 12 References ........................................................................................................................................
    [Show full text]
  • Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2010 Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis Ryan Fassnacht Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Physiology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2246 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Ryan C. Fassnacht 2010 All Rights Reserved Molecular Mechanisms Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Ryan Christopher Fassnacht, B.S. Hampden Sydney University, 2005 M.S. Virginia Commonwealth University, 2010 Director: Valeria Mas, Ph.D., Associate Professor of Surgery and Pathology Division of Transplant Department of Surgery Virginia Commonwealth University Richmond, Virginia July 9, 2010 Acknowledgement The Author wishes to thank his family and close friends for their support. He would also like to thank the members of the molecular transplant team for their help and advice. This project would not have been possible with out the help of Dr. Valeria Mas and her endearing
    [Show full text]
  • Genome-Wide Association Study of Copy Number Variations (Cnvs) with Opioid Dependence
    Neuropsychopharmacology (2015) 40, 1016–1026 & 2015 American College of Neuropsychopharmacology. All rights reserved 0893-133X/15 www.neuropsychopharmacology.org Genome-Wide Association Study of Copy Number Variations (CNVs) with Opioid Dependence Dawei Li*,1,2,3,4, Hongyu Zhao5,6, Henry R Kranzler7, Ming D Li8, Kevin P Jensen1, Tetyana Zayats1, Lindsay A Farrer9 and Joel Gelernter1,6,10 1 2 Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA; Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT, USA; 3Department of Computer Science, University of Vermont, Burlington, VT, USA; 4Neuroscience, Behavior, and Health Initiative, University of Vermont, Burlington, VT, USA; 5Department of Biostatistics, Yale School of Public Health, New Haven, 6 7 CT, USA; Department of Genetics, School of Medicine, Yale University, New Haven, CT, USA; Department of Psychiatry, University of 8 Pennsylvania School of Medicine and VISN 4 MIRECC, Philadelphia VAMC, Philadelphia, PA, USA; Department of Psychiatry and 9 Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA; Departments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Genetics and Genomics, Biostatistics, and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, MA, USA; 10VA Connecticut Healthcare Center, Department of Neurobiology, Yale University School of Medicine, New Haven, CT, USA Single-nucleotide polymorphisms that have been associated with opioid dependence (OD) altogether account for only a small proportion of the known heritability. Most of the genetic risk factors are unknown. Some of the ‘missing heritability’ might be explained by copy number variations (CNVs) in the human genome. We used Illumina HumanOmni1 arrays to genotype 5152 African-American and European-American OD cases and screened controls and implemented combined CNV calling methods.
    [Show full text]
  • Datasheet: VPA00331KT Product Details
    Datasheet: VPA00331KT Description: PRPF19 ANTIBODY WITH CONTROL LYSATE Specificity: PRPF19 Format: Purified Product Type: PrecisionAb™ Polyclonal Isotype: Polyclonal IgG Quantity: 2 Westerns Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Species Cross Reacts with: Mouse, Rat Reactivity N.B. Antibody reactivity and working conditions may vary between species. Product Form Purified IgG - liquid Preparation 20μl Rabbit polyclonal antibody purified by affinity chromatography Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN ) Stabilisers 3 Immunogen KLH-conjugated synthetic peptide corresponding to aa 4-33 of human PRPF19 External Database Links UniProt: Q9UMS4 Related reagents Entrez Gene: 27339 PRPF19 Related reagents Synonyms NMP200, PRP19, SNEV Page 1 of 3 Specificity Rabbit anti Human PRPF19 antibody recognizes PRPF19, also known as PRP19/PSO4 homolog, PRP19/PSO4 pre-mRNA processing factor 19 homolog, nuclear matrix protein 200, nuclear matrix protein NMP200 related to splicing factor PRP19, psoralen 4 and senescence evasion factor. The PRPF19 gene is the human homolog of yeast Pso4, a gene essential for cell survival and DNA repair (Beck et al.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • High-Throughput Discovery of Novel Developmental Phenotypes
    High-throughput discovery of novel developmental phenotypes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Dickinson, M. E., A. M. Flenniken, X. Ji, L. Teboul, M. D. Wong, J. K. White, T. F. Meehan, et al. 2016. “High-throughput discovery of novel developmental phenotypes.” Nature 537 (7621): 508-514. doi:10.1038/nature19356. http://dx.doi.org/10.1038/nature19356. Published Version doi:10.1038/nature19356 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:32071918 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nature. Manuscript Author Author manuscript; Manuscript Author available in PMC 2017 March 14. Published in final edited form as: Nature. 2016 September 22; 537(7621): 508–514. doi:10.1038/nature19356. High-throughput discovery of novel developmental phenotypes A full list of authors and affiliations appears at the end of the article. Abstract Approximately one third of all mammalian genes are essential for life. Phenotypes resulting from mouse knockouts of these genes have provided tremendous insight into gene function and congenital disorders. As part of the International Mouse Phenotyping Consortium effort to generate and phenotypically characterize 5000 knockout mouse lines, we have identified 410 Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms #Corresponding author: [email protected].
    [Show full text]
  • RBMX Is a Novel Hepatic Transcriptional Regulator of SREBP-1C Gene Response to High-Fructose Diet
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 581 (2007) 218–222 RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet Tadashi Takemotoa, Yoshihiko Nishiob,*, Osamu Sekineb, Chikako Ikeuchib, Yoshio Nagaib, Yasuhiro Maenob, Hiroshi Maegawab, Hiroshi Kimuraa, Atsunori Kashiwagib a Division of Molecular Genetics in Medicine, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga 520-2192, Japan b Division of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan Received 24 October 2006; accepted 1 December 2006 Available online 14 December 2006 Edited by Berend Wieringa nisms by which the high-fructose diet induces SREBP-1c gene Abstract In rodents a high-fructose diet induces metabolic derangements similar to those in metabolic syndrome. Previously expression in the liver. we suggested that in mouse liver an unidentified nuclear protein We previously reported a variation of susceptibility to these binding to the sterol regulatory element (SRE)-binding protein- metabolic disorders after monitoring the effects of high-fruc- 1c (SREBP-1c) promoter region plays a key role for the re- tose diet in different mouse strains [6]. Ten strains of inbred sponse to high-fructose diet. Here, using MALDI-TOF MASS mice were separated into CBA and DBA groups according technique, we identified an X-chromosome-linked RNA binding to their response to high-fructose diet. The hepatic mRNA motif protein (RBMX) as a new candidate molecule. In electro- expression of SREBP-1c in CBA/JN mice was remarkably ele- phoretic mobility shift assay, anti-RBMX antibody displaced the vated by high-fructose diet but not in DBA/2N.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • Original Article CDC5L Contributes to Malignant Cell Proliferation in Human Osteosarcoma Via Cell Cycle Regulation
    Int J Clin Exp Pathol 2016;9(10):10451-10457 www.ijcep.com /ISSN:1936-2625/IJCEP0031885 Original Article CDC5L contributes to malignant cell proliferation in human osteosarcoma via cell cycle regulation Yu Wang1,4*, Hong Chang2,4*, Di Gao3,4, Lei Wang4, Nan Jiang4, Bin Yu4 1Department of Orthopaedics, Chifeng Hospital, Inner Mongolia, China; 2Department of Orthopaedics, 421 Hospital of PLA, Guangzhou, China; 3Department of Orthopaedics, The University of Hong Kang, Shenzhen Hospital, Shenzhen, China; 4Department of Orthopaedics and Traumatology, Nanfang Hospital Southern Medical University, Guangzhou, China. *Equal contributors. Received May 9, 2016; Accepted July 22, 2016; Epub October 1, 2016; Published October 15, 2016 Abstract: Cell division cycle 5-like (CDC5L) has been reported in overexpressed in osteosarcoma (OS). However, its biological function in tumor biology was still unclear. Here, we firstly determined the expression of CDC5L in several OS cell lines, including Saos-2, SF-86, U2OS and SW1353, and found it was commonly upregulated in these four OS cells. Subsequently, Saos-2 and U2OS cells with higher CDC5L expression were transfected with interfering RNA tar- geting CDC5L. A set of functional assay was conducted on the two cell lines, including CCK-8, colony formation and flow cytometry assay. Our results indicated that CDC5L silencing significantly inhibited cell proliferation and arrested cell cycle at G2/M phase. Mechanically, Western blot analysis further confirmed knockdown of CDC5L remarkably down regulated the protein levels of CDK1, Cyclin B and PCNA. There findings further demonstrated that CDC5L play a crucial role in OS development and might be a promising therapeutic target of OS.
    [Show full text]
  • Role of MALAT1 in Gynecological Cancers: Pathologic and Therapeutic Aspects (Review)
    ONCOLOGY LETTERS 21: 333, 2021 Role of MALAT1 in gynecological cancers: Pathologic and therapeutic aspects (Review) FENG‑HUA QIAO1, MIN TU2 and HONG‑YAN LIU3 Departments of 1Gynecology and 2Orthopedics, Second People's Hospital of Jingmen; 3Department of Gynecology, Maternal and Child Health Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China Received June 28, 2020; Accepted February 2, 2021 DOI: 10.3892/ol.2021.12594 Abstract. Gynecological cancers, including breast, ovarian, 5. Targeting MALAT1 in gynecological cancer therapeutics uterine, vaginal, cervical and vulvar cancers are among the 6. Future research major threats to modern life, particularly to female health. 7. Conclusions Long non‑coding RNAs (lncRNAs) play critical roles in normal development of organisms, as well as the tumorigenesis process, and metastasis‑associated lung adenocarcinoma tran‑ 1. Introduction script 1 (MALAT1) is a large infrequently spliced lncRNA, which have been implicated in different gynecological cancers. Gynecologic cancer is any cancer of the female reproduc‑ MALAT1 is overexpressed in breast, ovarian, cervical and tive organs, including ovarian, uterine, vaginal, cervical and endometrial cancers, which initiates cancer progression by vulvar cancers. Generally, all women are at risk of devel‑ inducing changes in the expression of several anti‑apoptotic oping gynecological cancers, and risk increases with age (1). and epithelial‑to‑mesenchymal transition‑related genes. Each gynecologic cancer is unique, with different signs and Targeting MALAT1 is an important strategy to combat symptoms, different risk factors and different therapeutic strat‑ gynecological cancers, and application of RNA‑interference egies (2,3). Gynecological cancers are associated with high technology and chemotherapeutic process are crucial to target mortality rates worldwide as it is difficult to detect the cancers and minimize MALAT1 activity.
    [Show full text]